CASI Pharmaceuticals, Inc.
Pharmaceuticals · BEIJING, F4
PharmaceuticalsSEC Form D
CASI Pharmaceuticals, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 28, 2026, reporting $5,000,000 raised.
Incorporated in Cayman Islands and based in BEIJING, F4, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that CASI Pharmaceuticals, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Wei-Wu HeDirector
- Zhenbo SuDirector
- Thomas FolinsbeeDirector
- Alexander Y. WuDirector
- Xuebo ZengDirector
- Wei GaoExecutive Officer
- Kun QianExecutive Officer
- Chunhua WangExecutive Officer
- Hai HuangExecutive Officer
- Wei (Larry) ZhangExecutive Officer
- James HuangDirector
- Barbara Krebs-PohlDirector
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$3.0MRaised
FibroBiologics, Inc.
$200.0KRaised
Balsam Pharmaceuticals Co
$750.0KRaised
Eos SENOLYTIX, Inc.
$1.9MRaised
Liminatus Pharma, Inc.
$384.8KRaised